The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2025

Filed:

Jun. 03, 2020
Applicant:

Merz North America, Inc., Raleigh, NC (US);

Inventors:

Wojciech Danysz, Nidderau, DE;

Peter Kreymerman, Raleigh, NC (US);

Patrick Plitt, Bad Homburg, DE;

Assignee:

Merz North America, Inc., Raleigh, NC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 33/14 (2006.01); A61K 8/19 (2006.01); A61K 8/20 (2006.01); A61K 8/23 (2006.01); A61K 8/24 (2006.01); A61K 8/34 (2006.01); A61K 8/36 (2006.01); A61K 8/365 (2006.01); A61K 8/60 (2006.01); A61K 9/00 (2006.01); A61L 27/12 (2006.01); A61P 17/00 (2006.01); A61Q 19/08 (2006.01);
U.S. Cl.
CPC ...
A61K 33/14 (2013.01); A61K 8/19 (2013.01); A61K 8/20 (2013.01); A61K 8/23 (2013.01); A61K 8/24 (2013.01); A61K 8/345 (2013.01); A61K 8/36 (2013.01); A61K 8/365 (2013.01); A61K 8/60 (2013.01); A61L 27/12 (2013.01); A61P 17/00 (2018.01); A61Q 19/08 (2013.01); A61K 9/0019 (2013.01); A61K 2800/884 (2013.01); A61K 2800/91 (2013.01);
Abstract

A method for treating undesired implanted calcium phosphate tissue filler by administering an effective amount of a pharmaceutically acceptable hyperosmotic composition. The hyperosmotic composition may be hyperosmotic solution, particularly a hyperosmotic aqueous solution. The hyperosmotic composition is administration to an area containing the undesired calcium phosphate tissue filler. Administration of the hyperosmotic composition can reduce, dilute/or redistribute an undesired amount or accumulation of implanted calcium phosphate tissue filler implanted. Methods herein can ameliorate undesired filler that is implanted in an undesired or unintended location, that migrates to an undesired location, that results in an undesired visual result, and/or that results in undesired compression of surrounding tissue, and/or that results in pain, infection, and/or inflammation.


Find Patent Forward Citations

Loading…